Copyright
©The Author(s) 2025.
World J Clin Oncol. Jul 24, 2025; 16(7): 104727
Published online Jul 24, 2025. doi: 10.5306/wjco.v16.i7.104727
Published online Jul 24, 2025. doi: 10.5306/wjco.v16.i7.104727
Table 1 The pharmacokinetic and pharmacodynamic properties of propofol[10]
Properties | ||
Route of administration | Intravenous | |
Standard induction dose (mg/kg) | 1.5-2.5 | |
Onset of action (second) | 40-60 (‘one arm brain circulation’) | |
Duration of action (minute) | 3-10 | |
Volume of distribution (L/kg) | 5.8 | |
Protein binding | 97%-99% (mostly albumin) | |
Metabolism | Hepatic oxidation and conjugation to sulfate and glucuronide conjugates | |
Total body clearance (L/hour/kg) | 3.2 | |
Half-life | Initial (minute) | Approximately 40 |
Terminal (hour) | 4-7 | |
Context-sensitive (day) | 1-3 days after a 10-day infusion. The clinical effect of propofol is much shorter | |
Excretion | Primarily renal |
- Citation: Arun F, Arun O. Impact of propofol on gastrointestinal cancer outcomes: A review of cellular behavior, growth, and metastasis. World J Clin Oncol 2025; 16(7): 104727
- URL: https://www.wjgnet.com/2218-4333/full/v16/i7/104727.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i7.104727